Please Note: Microsoft has ended support of its older browsers as of January 2016. If you are seeing this message, you are viewing the site on an unsupported version of Internet Explorer (IE10 or older). To properly view this website, please upgrade your version of IE or access this site using a different browser. Thank you.
Sign InDues Join Privacy Contact Search
Home News Scrip

Scrip

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below.

John Lezcano
Corporate Account Manager
M: (631) 807-4971
John.lezcano@informa.com

Pharma intelligence | informa
P: (212) 652-2678
pharmaintelligence.informa.com

Scrip
Tuesday, May 26, 2020
Sanofi to sell most of its Regeneron stake, with much of it being re-purchased by Regeneron, but both stressed the...
Tuesday, May 26, 2020
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...
Tuesday, May 26, 2020
While Moderna and others frontrunners aim for a 2020 emergency use approval, Merck believes a more deliberate approach will pay...
Tuesday, May 26, 2020
Mounting evidence that President Trump's 'game changer' does more harm than good for COVID-19 patients. Novovax and Medicago among the latest...
Monday, May 25, 2020
As generalist investors continue to push higher the stock prices of biotech companies that announce the most tenuous of coronavirus...
Monday, May 25, 2020
In a bipartisan move, the US Senate is moving to impose new rules on companies - including those from China...
Monday, May 25, 2020
First-line lung cancer approval will expand potential market for Takeda's ALK contender but the latecomer is also facing some well-established...
Sunday, May 24, 2020
Kynmobi is an important approval for parent company Sumitomo Dainippon ahead of the loss of exclusivity for Latuda. Sunovion hopes...
Friday, May 22, 2020
The company said a planned 9 June advisory committee to review the NDA for obeticholic acid in NASH has been...
Friday, May 22, 2020
Kadmon’s treatment for graft-versus-host disease, belumosudil continues to perform well in its pivotal ROCKstar study, setting the stage for a...